Spada M, Porta F, Righi D, Gazzera C, Tandoi F, Ferrero I, Fagioli F, Sanchez MBH, Calvo PL, Biamino E, Bruno S, Gunetti M, Contursi C, Lauritano C, Conio A, Amoroso A, Salizzoni M, Silengo L, Camussi G, Romagnoli R (2020) Intrahepatic administration of human liver stem cells in infants with inherited neonatal-onset hyperammonemia: a phase I study
This FDA-approved weight loss injection operates by activating two receptor pathwaysGLP-1 and GIPsimultaneously
Different GLP-1 receptor agonists do not result in the same amount of weight loss
2015 Feb 6;12:7
Injecting directly into stomach tissue would damage the organ and prevent proper drug delivery
Linking temperature, cation concentration and water activity for the B to Z conformational transition in DNA